BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.

Abstract

These results suggest that glutamate release inhibitors such as BW619C89 may provide an alternative to excitatory amino acid receptor antagonists in the treatment of focal cerebral ischemia and stroke.